Given that cardiovascular disease is the top cause of morbidity/mortality in patients with MASLD, do you perform any additional screening and/or testing for these patients to minimize this impact?

MASLD should likely be thought of as part of a cardiometabolic disease with a wide spectrum of manifestations. I see my clinic as part of this management, but I do not do a complete cardiac assessment routinely on all my patients. I do not do this simply for the challenge of addressing all these issues for each patient. For all patients, I do get lipids and a screening for diabetes in our standard workup. For patients with cardiovascular risks, I will encourage them to discuss CT calcium scores with their pcp or cardiology team. This is an aspect of MASLD patients that needs to be addressed, but in my clinic, we currently do basic cardiovascular risk screening and ask them to follow up with pcp/cardiology if they have a positive screen.